Home › Cytomegalovirus Infections › New York
Cytomegalovirus Infections clinical trials in New York
5 studies for Cytomegalovirus Infections are looking for participants at sites in New York.
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
- New York Medical College, Valhalla
RecruitingPhase 3
1 Day – 30 Years · All sexes · Updated Sep 11, 2026 · NCT07225972R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
- Columbia University Medical Center / New-York Presbyterian, New York
RecruitingPhase 1
3 Months – 26 Years · All sexes · Updated Jul 30, 2026 · NCT06926894R-MVST Cells for Treatment of Viral Infections
- Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05183490Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
- New York Medical College, Valhalla
RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Aug 8, 2025 · NCT03266640Long-Term Outcomes of Children With Congenital CMV in New York State
- Stony Brook Children's Hospital, Stony Brook
RecruitingObservational study
0 Days – 1 Year · All sexes · Updated May 13, 2025 · NCT06226558From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.